Wuhan Financial Statements From 2010 to 2024
| WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
Check Wuhan General financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wuhan General's main balance sheet or income statement drivers, such as , as well as many indicators such as . Wuhan financial statements analysis is a perfect complement when working with Wuhan General Valuation or Volatility modules.
Wuhan |
Wuhan General Gr Company Shares Outstanding Analysis
Wuhan General's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Wuhan General Shares Outstanding | 33.93 M |
Most of Wuhan General's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Wuhan General Gr is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Wuhan General Gr has 33.93 M of shares currently outstending. This is 81.21% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 94.07% higher than that of the company.
Wuhan General Gr Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Wuhan General's current stock value. Our valuation model uses many indicators to compare Wuhan General value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Wuhan General competition to find correlations between indicators driving Wuhan General's intrinsic value. More Info.Wuhan General Gr is rated fourth in return on equity category among its peers. It is rated first in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Wuhan General by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Wuhan General's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Wuhan General Financial Statements
Wuhan General investors utilize fundamental indicators, such as revenue or net income, to predict how Wuhan Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Wuhan General Group , Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol -based products under the Dr. Wuhan General Group , Inc. is headquartered in Pointe-Claire, Canada. Wuhan General operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 700 people.
Pair Trading with Wuhan General
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Wuhan General position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan General will appreciate offsetting losses from the drop in the long position's value.Moving together with Wuhan Pink Sheet
Moving against Wuhan Pink Sheet
| 0.72 | INIS | International Isotopes | PairCorr |
| 0.54 | ELTP | Elite Pharma | PairCorr |
| 0.45 | YCBD-PA | cbdMD Inc | PairCorr |
| 0.38 | VAXX | Vaxxinity | PairCorr |
The ability to find closely correlated positions to Wuhan General could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Wuhan General when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Wuhan General - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Wuhan General Gr to buy it.
The correlation of Wuhan General is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Wuhan General moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Wuhan General Gr moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Wuhan General can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Wuhan Pink Sheet
If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |